Atorvastatin Calcium
Product Images NDC 68071-2788

5 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2788). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 2788 9)

Pdp (68071 2788 9)
Label for Atorvastatin Calcium 40 mg tablets from NuCare Pharmaceuticals, Inc. The label indicates a package of 90 tablets with product number R1522090 and prescription-only status, includes the NDC 68071-2788-9, storage instructions, and barcode information. Additional manufacturing and lot details are present, along with a reference to see the manufacturer's label for full ingredients and a warning to keep out of reach of children.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing the effect of Atorvastatin Calcium 10 mg/day on the cumulative incidence of non-fatal myocardial infarction or coronary heart disease death over approximately 3.5 years. The graph compares Atorvastatin and placebo, with cumulative incidence (%) on the y-axis and time in years on the x-axis. The Atorvastatin line shows lower incidence compared to placebo.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph titled 'Effect of Atorvastatin Calcium 10 mg/day on Time to Occurrence of Major Cardiovascular Event in CARDS.' It compares cumulative hazard percentages over up to 5 years of follow-up between placebo and atorvastatin groups, showing a lower hazard for the atorvastatin group. The graph includes hazard ratio (HR=0.63) and p-value (0.001) statistical annotations.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the effect of Atorvastatin Calcium 80 mg/day versus 10 mg/day on the time to occurrence of major cardiovascular events over five years. The x-axis represents time in years to first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. Two lines represent the 10 mg and 80 mg doses, with a hazard ratio of 0.78 (95% CI 0.69-0.89) and p=0.0002 indicated.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium dihydrate, showing its molecular arrangement with calcium ion and water molecules indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.